<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35566351</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1420-3049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecules (Basel, Switzerland)</Title>
          <ISOAbbreviation>Molecules</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">3001</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules27093001</ELocationID>
        <Abstract>
          <AbstractText>Thyroid autoimmunity in Graves' disease (GD) is accompanied by Graves' orbitopathy (GO) in 40% of the cases. Orbital fibroblasts (OF) play a key role in the pathogenesis and cigarette smoking is a known deteriorating factor. Alongside conventional cigarettes (CC) new alternatives became available for smokers, including heated tobacco products (HTP) and E-cigarettes (ECIG). We aimed to study the cellular effects of smoke extracts (SE) in orbital fibroblasts. Primary OF cultures from GO and NON-GO orbits were exposed to different concentrations of SE (1%, 50%) and the changes were followed using Real Time Cell Electronic Sensing (RT-CES). Untreated GO and NON-GO cells had different maximum cell index (CI) values of 3.3 and 2.79 respectively (<i>p</i> &amp;lt; 0.0001). CC, HTP and ECIG treated NON-GO fibroblasts exhibited peak CIs of 2.62, 3.32 and 3.41 while treated GO cells' CIs were higher, 5.38, 6.25 and 6.33, respectively (<i>p</i> &amp;lt; 0.0001). The metabolic activity (MTT) decreased (<i>p</i> &amp;lt; 0.001) and hyaluronan production doubled (<i>p</i> &amp;lt; 0.02) after 50% of CC SE treatment in all cell cultures. GO fibroblasts were more sensitive to low concentration SE then NON-GO fibroblasts (<i>p</i> &amp;lt; 0.0001). The studied SEs exerted different effects. RT-CES is a sensitive technique to detect the effects of very low concentration of SE on fibroblasts.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Aranyosi</LastName>
            <ForeName>Janos K</ForeName>
            <Initials>JK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Doctoral School of Clinical Sciences, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galgoczi</LastName>
            <ForeName>Erika</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Divison of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erdei</LastName>
            <ForeName>Annamaria</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Divison of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Katko</LastName>
            <ForeName>Monika</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9791-9288</Identifier>
            <AffiliationInfo>
              <Affiliation>Divison of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fodor</LastName>
            <ForeName>Mariann</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ujhelyi</LastName>
            <ForeName>Zoltan</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0001-9724-0614</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bacskay</LastName>
            <ForeName>Ildiko</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0001-8663-2890</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Healthcare Industry, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagy</LastName>
            <ForeName>Endre V</ForeName>
            <Initials>EV</Initials>
            <AffiliationInfo>
              <Affiliation>Divison of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ujhelyi</LastName>
            <ForeName>Bernadett</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-5760-3350</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Doctoral School of Clinical Sciences, University of Debrecen, Nagyerdei Körút 98, 4032 Debrecen, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Molecules</MedlineTA>
        <NlmUniqueID>100964009</NlmUniqueID>
        <ISSNLinking>1420-3049</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000079522">E-Cigarette Vapor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073865" MajorTopicYN="Y">Cigarette Smoking</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079522" MajorTopicYN="Y">E-Cigarette Vapor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066300" MajorTopicYN="Y">Electronic Nicotine Delivery Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004581" MajorTopicYN="N">Electronics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049970" MajorTopicYN="Y">Graves Ophthalmopathy</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="Y">Tobacco Products</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Graves orbitopathy (GO)</Keyword>
        <Keyword MajorTopicYN="N">alternative tobacco products</Keyword>
        <Keyword MajorTopicYN="N">cigarette smoke extract</Keyword>
        <Keyword MajorTopicYN="N">real time cell electronic sensing (RT CES)</Keyword>
        <Keyword MajorTopicYN="N">retrobulbar fibroblast</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>1</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35566351</ArticleId>
        <ArticleId IdType="pmc">PMC9102878</ArticleId>
        <ArticleId IdType="doi">10.3390/molecules27093001</ArticleId>
        <ArticleId IdType="pii">molecules27093001</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., Smith P.A. The spectrum of thyroid disease in a community: The Whickham survey. Clin. Endocrinol. 1977;7:481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2265.1977.tb01340.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chin Y.H., Ng C.H., Lee M.H., Koh J.W.H., Kiew J., Yang S.P., Sundar G., Khoo C.M. Prevalence of thyroid eye disease in Graves’ disease: A meta-analysis and systematic review. Clin. Endocrinol. 2020;93:363–374. doi: 10.1111/cen.14296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cen.14296</ArticleId>
            <ArticleId IdType="pubmed">32691849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahn R.S. Graves’ ophthalmopathy. N. Engl. J. Med. 2010;362:726–738. doi: 10.1056/NEJMra0905750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra0905750</ArticleId>
            <ArticleId IdType="pmc">PMC3902010</ArticleId>
            <ArticleId IdType="pubmed">20181974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Smith T.J. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Investig. Ophthalmol. Vis. Sci. 2014;55:1735–1748. doi: 10.1167/iovs.14-14002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.14-14002</ArticleId>
            <ArticleId IdType="pmc">PMC3968932</ArticleId>
            <ArticleId IdType="pubmed">24651704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blandford A.D., Zhang D., Chundury R.V., Perry J.D. Dysthyroid optic neuropathy: Update on pathogenesis, diagnosis, and management. Expert Rev. Ophthalmol. 2017;12:111–121. doi: 10.1080/17469899.2017.1276444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17469899.2017.1276444</ArticleId>
            <ArticleId IdType="pmc">PMC5535799</ArticleId>
            <ArticleId IdType="pubmed">28775762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otto E.A., Ochs K., Hansen C., Wall J.R., Kahaly G.J. Orbital tissue-derived T lymphocytes from patients with Graves’ ophthalmopathy recognize autologous orbital antigens. J. Clin. Endocrinol. Metab. 1996;81:3045–3050. doi: 10.1210/jcem.81.8.8768872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.81.8.8768872</ArticleId>
            <ArticleId IdType="pubmed">8768872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith T.J. Insights into the role of fibroblasts in human autoimmune diseases. Clin. Exp. Immunol. 2005;141:388–397. doi: 10.1111/j.1365-2249.2005.02824.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2249.2005.02824.x</ArticleId>
            <ArticleId IdType="pmc">PMC1809453</ArticleId>
            <ArticleId IdType="pubmed">16045727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szucs-Farkas Z., Toth J., Kollar J., Galuska L., Burman K.D., Boda J., Leovey A., Varga J., Ujhelyi B., Szabo J., et al.  Volume changes in intra- and extraorbital compartments in patients with Graves’ ophthalmopathy: Effect of smoking. Thyroid. 2005;15:146–151. doi: 10.1089/thy.2005.15.146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/thy.2005.15.146</ArticleId>
            <ArticleId IdType="pubmed">15753674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cawood T.J., Moriarty P., O’Farrelly C., O’Shea D. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. J. Clin. Endocrinol. Metab. 2007;92:59–64. doi: 10.1210/jc.2006-1824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2006-1824</ArticleId>
            <ArticleId IdType="pubmed">17047020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon J.S., Lee H.J., Chae M.K., Lee S.Y., Lee E.J. Cigarette smoke extract-induced adipogenesis in Graves’ orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress. J. Endocrinol. 2013;216:145–156. doi: 10.1530/JOE-12-0257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JOE-12-0257</ArticleId>
            <ArticleId IdType="pubmed">23143154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mack W.P., Stasior G.O., Cao H.J., Stasior O.G., Smith T.J. The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthalmic Plast Reconstr. Surg. 1999;15:260–271. doi: 10.1097/00002341-199907000-00007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00002341-199907000-00007</ArticleId>
            <ArticleId IdType="pubmed">10432522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health  . How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Centers for Disease Control and Prevention (US); Atlanta, GA, USA: 2010. Publications and Reports of the Surgeon General.</Citation>
        </Reference>
        <Reference>
          <Citation>Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum. 2004;83:1–1438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4781536</ArticleId>
            <ArticleId IdType="pubmed">15285078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pesch B., Kendzia B., Gustavsson P., Jöckel K.H., Johnen G., Pohlabeln H., Olsson A., Ahrens W., Gross I.M., Brüske I., et al.  Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int. J. Cancer. 2012;131:1210–1219. doi: 10.1002/ijc.27339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.27339</ArticleId>
            <ArticleId IdType="pmc">PMC3296911</ArticleId>
            <ArticleId IdType="pubmed">22052329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosetti C., Lucenteforte E., Silverman D.T., Petersen G., Bracci P.M., Ji B.T., Negri E., Li D., Risch H.A., Olson S.H., et al.  Cigarette smoking and pancreatic cancer: An analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4) Ann. Oncol. 2012;23:1880–1888. doi: 10.1093/annonc/mdr541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/annonc/mdr541</ArticleId>
            <ArticleId IdType="pmc">PMC3387822</ArticleId>
            <ArticleId IdType="pubmed">22104574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang P.S., Chen T.Y., Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis. Int. J. Cancer. 2009;124:2406–2415. doi: 10.1002/ijc.24191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.24191</ArticleId>
            <ArticleId IdType="pubmed">19142968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prummel M.F., Wiersinga W.M. Smoking and risk of Graves’ disease. JAMA. 1993;269:479–482. doi: 10.1001/jama.1993.03500040045034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.1993.03500040045034</ArticleId>
            <ArticleId IdType="pubmed">8419666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancelada L., Sleiman M., Tang X., Russell M.L., Montesinos V.N., Litter M.I., Gundel L.A., Destaillats H. Heated Tobacco Products: Volatile Emissions and Their Predicted Impact on Indoor Air Quality. Environ. Sci. Technol. 2019;53:7866–7876. doi: 10.1021/acs.est.9b02544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.est.9b02544</ArticleId>
            <ArticleId IdType="pubmed">31150216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goniewicz M.L., Knysak J., Gawron M., Kosmider L., Sobczak A., Kurek J., Prokopowicz A., Jablonska-Czapla M., Rosik-Dulewska C., Havel C., et al.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control. 2014;23:133–139. doi: 10.1136/tobaccocontrol-2012-050859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050859</ArticleId>
            <ArticleId IdType="pmc">PMC4154473</ArticleId>
            <ArticleId IdType="pubmed">23467656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farsalinos K.E., Yannovits N., Sarri T., Voudris V., Poulas K., Leischow S.J. Carbonyl emissions from a novel heated tobacco product (IQOS): Comparison with an e-cigarette and a tobacco cigarette. Addiction. 2018;113:2099–2106. doi: 10.1111/add.14365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.14365</ArticleId>
            <ArticleId IdType="pubmed">29920842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallock N., Böss L., Burk R., Danziger M., Welsch T., Hahn H., Trieu H.L., Hahn J., Pieper E., Henkler-Stephani F., et al.  Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks. Arch. Toxicol. 2018;92:2145–2149. doi: 10.1007/s00204-018-2215-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00204-018-2215-y</ArticleId>
            <ArticleId IdType="pmc">PMC6002459</ArticleId>
            <ArticleId IdType="pubmed">29730817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farsalinos K.E., Yannovits N., Sarri T., Voudris V., Poulas K. Nicotine Delivery to the Aerosol of a Heat-Not-Burn Tobacco Product: Comparison With a Tobacco Cigarette and E-Cigarettes. Nicotine Tob. Res. 2018;20:1004–1009. doi: 10.1093/ntr/ntx138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntx138</ArticleId>
            <ArticleId IdType="pubmed">28637344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zagoriti Z., El Mubarak M.A., Farsalinos K., Topouzis S. Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro. Toxics. 2020;8:9.  doi: 10.3390/toxics8010009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxics8010009</ArticleId>
            <ArticleId IdType="pmc">PMC7151757</ArticleId>
            <ArticleId IdType="pubmed">32033401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiemstra P.S., Bals R. Basic science of electronic cigarettes: Assessment in cell culture and in vivo models. Respir. Res. 2016;17:127. doi: 10.1186/s12931-016-0447-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12931-016-0447-z</ArticleId>
            <ArticleId IdType="pmc">PMC5055681</ArticleId>
            <ArticleId IdType="pubmed">27717371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barna S., Rózsa D., Varga J., Fodor A., Szilasi M., Galuska L., Garai I. First comparative results about the direct effect of traditional cigarette and e-cigarette smoking on lung alveolocapillary membrane using dynamic ventilation scintigraphy. Nucl. Med. Commun. 2019;40:153–158. doi: 10.1097/MNM.0000000000000957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MNM.0000000000000957</ArticleId>
            <ArticleId IdType="pubmed">30531407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isik A.G., Zoi Z., Stavros T., Konstantinos P. Oxidative stress induced by electronic nicotine delivery systems (ENDS): Focus on respiratory system. Curr. Opin. Toxicol. 2019;13:81–89.</Citation>
        </Reference>
        <Reference>
          <Citation>Prabhakar B.S., Bahn R.S., Smith T.J. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr. Rev. 2003;24:802–835. doi: 10.1210/er.2002-0020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2002-0020</ArticleId>
            <ArticleId IdType="pubmed">14671007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorisky A., Pardasani D., Gagnon A., Smith T.J. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J. Clin. Endocrinol. Metab. 1996;81:3428–3431. doi: 10.1210/jcem.81.9.8784110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.81.9.8784110</ArticleId>
            <ArticleId IdType="pubmed">8784110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Starkey K.J., Janezic A., Jones G., Jordan N., Baker G., Ludgate M. Adipose thyrotrophin receptor expression is elevated in Graves’ and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J. Mol. Endocrinol. 2003;30:369–380. doi: 10.1677/jme.0.0300369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1677/jme.0.0300369</ArticleId>
            <ArticleId IdType="pubmed">12790806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith T.J., Tsai C.C., Shih M.J., Tsui S., Chen B., Han R., Naik V., King C.S., Press C., Kamat S., et al.  Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid. 2008;18:983–988. doi: 10.1089/thy.2007.0404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/thy.2007.0404</ArticleId>
            <ArticleId IdType="pmc">PMC2574420</ArticleId>
            <ArticleId IdType="pubmed">18788919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szulcek R., Bogaard H.J., van Nieuw Amerongen G.P. Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J. Vis. Exp. 2014:e51300. doi: 10.3791/51300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wegener J., Keese C.R., Giaever I. Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp. Cell Res. 2000;259:158–166. doi: 10.1006/excr.2000.4919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/excr.2000.4919</ArticleId>
            <ArticleId IdType="pubmed">10942588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keese C.R., Wegener J., Walker S.R., Giaever I. Electrical wound-healing assay for cells in vitro. Proc. Natl. Acad. Sci. USA. 2004;101:1554–1559. doi: 10.1073/pnas.0307588100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0307588100</ArticleId>
            <ArticleId IdType="pmc">PMC341773</ArticleId>
            <ArticleId IdType="pubmed">14747654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Róka E., Ujhelyi Z., Deli M., Bocsik A., Fenyvesi É., Szente L., Fenyvesi F., Vecsernyés M., Váradi J., Fehér P., et al.  Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes. Molecules. 2015;20:20269–20285. doi: 10.3390/molecules201119694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules201119694</ArticleId>
            <ArticleId IdType="pmc">PMC6332255</ArticleId>
            <ArticleId IdType="pubmed">26569209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarantola M., Schneider D., Sunnick E., Adam H., Pierrat S., Rosman C., Breus V., Sönnichsen C., Basché T., Wegener J., et al.  Cytotoxicity of metal and semiconductor nanoparticles indicated by cellular micromotility. ACS Nano. 2009;3:213–222. doi: 10.1021/nn800721j.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/nn800721j</ArticleId>
            <ArticleId IdType="pubmed">19206269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao C., Lachance B., Sunahara G., Luong J.H. Assessment of cytotoxicity using electric cell-substrate impedance sensing: Concentration and time response function approach. Anal. Chem. 2002;74:5748–5753. doi: 10.1021/ac025848f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac025848f</ArticleId>
            <ArticleId IdType="pubmed">12463358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarantola M., Marel A.K., Sunnick E., Adam H., Wegener J., Janshoff A. Dynamics of human cancer cell lines monitored by electrical and acoustic fluctuation analysis. Integr. Biol. 2010;2:139–150. doi: 10.1039/b920815a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/b920815a</ArticleId>
            <ArticleId IdType="pubmed">20473392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kósa D., Pető Á., Fenyvesi F., Váradi J., Vecsernyés M., Gonda S., Vasas G., Fehér P., Bácskay I., Ujhelyi Z. Formulation of Novel Liquid Crystal (LC) Formulations with Skin-Permeation-Enhancing Abilities of Plantago lanceolata (PL) Extract and Their Assessment on HaCaT Cells. Molecules. 2021;26:1023.  doi: 10.3390/molecules26041023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules26041023</ArticleId>
            <ArticleId IdType="pmc">PMC7919469</ArticleId>
            <ArticleId IdType="pubmed">33672029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bagnaninchi P.O., Drummond N. Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing. Proc. Natl. Acad. Sci. USA. 2011;108:6462–6467. doi: 10.1073/pnas.1018260108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1018260108</ArticleId>
            <ArticleId IdType="pmc">PMC3080969</ArticleId>
            <ArticleId IdType="pubmed">21464296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yalçin M., Barutcigil C., Umar I., Bozkurt B.S., Hakki S.S. Cytotoxicity of hemostatic agents on the human gingival fibroblast. Eur. Rev. Med. Pharmacol. Sci. 2013;17:984–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23640448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahida B., Johnson P.S., Jain R., Brorson H., Åsman P., Lantz M., Planck T. Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves’ ophthalmopathy patients. Endocr. Connect. 2019;8:1230–1239. doi: 10.1530/EC-19-0319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EC-19-0319</ArticleId>
            <ArticleId IdType="pmc">PMC6733370</ArticleId>
            <ArticleId IdType="pubmed">31394503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giebe S., Cockcroft N., Hewitt K., Brux M., Hofmann A., Morawietz H., Brunssen C. Cigarette smoke extract counteracts atheroprotective effects of high laminar flow on endothelial function. Redox Biol. 2017;12:776–786. doi: 10.1016/j.redox.2017.04.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2017.04.008</ArticleId>
            <ArticleId IdType="pmc">PMC5397582</ArticleId>
            <ArticleId IdType="pubmed">28432984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galgoczi E., Jeney F., Gazdag A., Erdei A., Katko M., Nagy D.M., Ujhelyi B., Steiber Z., Gyory F., Berta E., et al.  Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts. J. Endocrinol. 2016;229:187–196. doi: 10.1530/JOE-15-0524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JOE-15-0524</ArticleId>
            <ArticleId IdType="pubmed">26979769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahn R.S., Gorman C.A., Woloschak G.E., David C.S., Johnson P.M., Johnson C.M. Human retroocular fibroblasts in vitro: A model for the study of Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 1987;65:665–670. doi: 10.1210/jcem-65-4-665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem-65-4-665</ArticleId>
            <ArticleId IdType="pubmed">3654911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernhard D., Huck C.W., Jakschitz T., Pfister G., Henderson B., Bonn G.K., Wick G. Development and evaluation of an in vitro model for the analysis of cigarette smoke effects on cultured cells and tissues. J. Pharmacol. Toxicol. Methods. 2004;50:45–51. doi: 10.1016/j.vascn.2004.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vascn.2004.01.003</ArticleId>
            <ArticleId IdType="pubmed">15233967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solly K., Wang X., Xu X., Strulovici B., Zheng W. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol. 2004;2:363–372. doi: 10.1089/adt.2004.2.363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/adt.2004.2.363</ArticleId>
            <ArticleId IdType="pubmed">15357917</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
